Matthew Lang Lyell Immunopharma, Inc. (LYEL) insider trading activity
Matthew Lang is Chief Business Officer of Lyell Immunopharma, Inc.. Currently has a direct ownership of 50,000 shares of LYEL, which is worth approximately $30,500. The most recent transaction as insider was on Feb 09, 2024, when has been sold 50,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
50K
0%
3M change
n/a
12M change
Total Value Held
$30,500
Matthew Lang Transaction History
Also insider at
ML
Matthew Lang
Chief Business Officer
Brisbane, CA